Krakowski M, Czobor P, Volavka J
Nathan Kline Institute for Psychiatric Research, New York, NY 10962, USA.
Psychiatry Res. 1997 Jun 16;71(1):19-26. doi: 10.1016/s0165-1781(97)03076-x.
This study examined depressive symptoms in acute schizophrenic episodes and their relationship to neuroleptic treatment. Sixty-three depressed and 62 non-depressed acutely exacerbated schizophrenic patients were evaluated with the Brief Psychiatric Rating Scale, the Scale for the Assessment of Positive Symptoms, the Simpson-Angus Extrapyramidal Scale, and the Hamilton Rating Scale for Depression. Subjects were then randomly assigned to different haloperidol plasma levels and followed for 3 weeks. Overall, depression improved with treatment of the acute psychosis, but a positive association between extrapyramidal side effects and depressive symptoms emerged over time. Depressive symptoms tended to be positively related to haloperidol plasma levels. The results suggest that depressive symptoms in schizophrenia are heterogeneous in origin; while neuroleptics can ameliorate depressive symptoms inherent in the acute schizophrenic episode, they can also contribute to depression.
本研究调查了急性精神分裂症发作时的抑郁症状及其与抗精神病药物治疗的关系。采用简明精神病评定量表、阳性症状评定量表、辛普森-安格斯锥体外系反应量表和汉密尔顿抑郁评定量表,对63名伴有抑郁症状和62名无抑郁症状的急性加重期精神分裂症患者进行了评估。然后将受试者随机分配至不同的氟哌啶醇血药浓度水平,并随访3周。总体而言,随着急性精神病性症状得到治疗,抑郁症状有所改善,但随着时间推移,锥体外系副作用与抑郁症状之间出现了正相关。抑郁症状往往与氟哌啶醇血药浓度呈正相关。结果表明,精神分裂症中的抑郁症状来源各异;虽然抗精神病药物可以改善急性精神分裂症发作时固有的抑郁症状,但它们也可能导致抑郁。